Don't miss your chance to register for the virtual ISMO After ASCO meeting - happening tomorrow from 7 to 9 p.m. 📨 [email protected] to register. Details & agenda: bit.ly/3RZIBbs Seamus O’Reilly MD PhD Jack Gleeson Fergus Keane Siobhan Gaynor Caitríona Goggin

Great meeting last night for ISMO after ASCO - 120+ attendees discussing the latest developments in cancer research. Recording available shortly. Thanks Seamus O’Reilly MD PhD Siobhan Gaynor Jack Gleeson Fergus Keane Caitríona Goggin

Pancreas Cancer 2024: Translating Genomic Findings into Clinical Actionability— Eileen M O’Reilly will address this topic in a keynote lecture at the AACR Special Conference on Advances in Pancreatic Cancer Research (September 15-18, Boston). bit.ly/3Wg3L7I #AACRpan24

"takes a long time #perseverance #resilience to overcome the #hurdles but so rewarding when the #seeds planted start to bear #fruit" - MSK Department of Medicine ESMO - Eur. Oncology Barcelona, I will finally meet you in Sept! Stay tuned for great stuffs for #PancreaticCancer! #POLAR #KRAS #ESMO24

We applaud the appointment of Prof Grainne O’Kane as the Pat Smullen Chair in Pancreatic Cancer University College Dublin The position is part-funded (€900K over 5 years) through the Pat Smullen Pancreatic Cancer Fund, with matching funding from NCCP Read more: bit.ly/4fXyJta

Thrilled to see the appointment of my great friend, colleague, collaborator and all round super human Grainne O'Kane Can’t wait to see her turn pancreas cancer management in Ireland and world over on its head! 💪💪💪 Fantastic appointment 👏University College Dublin CancerTrialsIreland 🌈

Excited to share that my undergrad thesis on Lynch syndrome and somatic mismatch repair deficiency in pancreas cancer was published in JAMA Oncology!🧬 A million thanks to Emily Harrold Eileen M O’Reilly Wungki Park, MD MS Fergus Keane+ countless others for all the guidance and support😊

The study results suggest that orthogonal MS testing is critical to identify MSI-H in PC and patients with MSI-H PC should be treated with immune checkpoint blockade therapy. ja.ma/4gbePuZ Catherine O’Connor Eileen M O’Reilly

Listen to an interview with Eileen M O’Reilly author of "Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer," with Vivek Subbiah, MD. Hosted on AMA Ed Hub™. ja.ma/4ebd9Q9

We welcome Dr. Umair Aleem, Consultant Medical Oncologist to our Cancer Services team at University Hospital Limerick. Read more about Dr. Aleem➡️bit.ly/4efvGuE #HSEMidWest

Fergus Keane giving a fantastic overview of systemic therapies in pancreatic cancer SRS and SBRT Symposium symposium Grainne O'Kane Pancreatic Cancer Ireland

Join MSK gastrointestinal medical oncologist Wungki Park, MD MS today for his presentation on preliminary safety & clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults w/ advanced #pancreatic, #colorectal, & #NSCLC. bit.ly/4d6Npn9

Niche 2 after two doses of nivolumab and one dose of ipi and surgery. 100% of patients with MSI high colon cancer relapse free at 3 years. Arguably preop IO should be a new care standard in MSI high colon cancer.

KRAS12D targeting is promising ! Wonderful presentation by Wungki Park, MD MS Memorial Sloan Kettering Cancer Center ESMO - Eur. Oncology

#FIC ! #KRAS #G12D protein #degrader evaluated in heavily treated PDAC in 3L+ setting. Responses in non-chemotherapeutic backbone in this setting is not expected so this very encouraging! Thanks for sharing! #ESMO24 ESMO - Eur. Oncology MSK Department of Medicine MSKCC Center for Pancreatic Cancer Research

👏Congratulations Laura Morrison for leading out on this research. Circulating Interleukin-17A is associated with executive cognitive function in middle aged adults with and without T2 diabetes. sciencedirect.com/science/articl… Dementia Research Network Ireland Tallaght University Hospital (TUH) TCD Medical Gerontology Nollaig Bourke

Great talk from Dr. Eileen M O’Reilly at #TransOncXVII organized by Prof. ProfJohnCrown & colleagues. Tour de force review of latest pancreas cancer translational & clinical research, Kras therapeutics are increasing commonalities between lung & pancreas cancer research.

Fantastic presentation by Laura Morrison at the Irish Gerontological Society 👏👏 #igs Sean Kennelly Adam Dyer

#TumorBoardTuesday 30% of all cancers are KRAS mutated‼️ And in #PancreaticCancer KRAS has been the most elusive🎯 📢So tune in Tuesday, 10-15-24 at 8PM ET as Wungki Park, MD MS & Brinda Alagesan🗣️targeting KRASG12D in Pancreatic Cancer RT and bring others into the discussion‼️

Pleasure to discuss personalised approaches for patients #pancreaticcancer ➡️germline testing for all ➡️molecular profiling & personalised chemotx ➡️precision surgery : understanding anatomical, biological & patient factors that select the right patient my_UEG Pancreatic Cancer Ireland